C/ BASE NO CPA 2026_6 - TALAZOPARIB 0.25 MG CÁPS
€27,856
Award value
215 contracts won, worth €3.4M, from 38 public buyers.
Main sectors Medical equipment & pharmaceuticals 215
We email you when this company wins a new contract. Free, one click to stop.
Record
Each dot is one award, placed on its date and sized by its value. Where a year holds more than 80 awards, its 80 largest are drawn.
Relations
Shares of the 215 contracts this company has won.
Radar
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
€7,421 current contract
2 months
Dec 2026
€18,483 current contract
2 months
Dec 2026
€2,202 current contract
2 months
Dec 2026
€1,651 current contract
2 months
Dec 2026
€1,487 current contract
2 months
Dec 2026
€17,696 current contract
2 months
Dec 2026
€2,895 current contract
2 months
Dec 2026
€30,414 current contract
2 months
Dec 2026
€10,263 current contract
2 months
Jan 2027
€13,599 current contract
2 months
Jan 2027
Prices
€8,022
over 200 awards with a published amount
At estimate
typical award, over 200 contracts with both figures
4 months
median, over 33 contracts with a known length
Territory
Shares of the 136 contracts that name a region.
Register
Each bar compares an award with the largest on this page, €48,536.
€27,856
Award value
€2,430
Award value
€36,100
Award value
€10,263
Award value
€13,599
Award value
€2,895
Award value
€17,696
Award value
€1,651
Award value
€135
Award value
€19,966
Award value
€26,221
Award value
€28,500
Award value
€8,806
Award value
€2,202
Award value
€2,552
Award value
€25,098
Award value
€578
Award value
€18,483
Award value
€48,536
Award value
€1,638
Award value